Hyperfine, Inc.
Current role
HYPR
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
Proxy statement
Proxy statement
Start not stated–2023-09-30
Recorded roles and earnings-call appearances connecting this person to public companies.
HYPR
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Hyperfine, Inc. (HYPR) | M.D., Chief Medical Officer and Chief Strategy Officer | $407,077 | $1,534,072 |
| 2021 | Hyperfine, Inc. (HYPR) | M.D., Chief Medical Officer and Chief Strategy Officer | $331,250 | $583,445 |
| 2020 | Hyperfine, Inc. (HYPR) | M.D., Chief Medical Officer and Chief Strategy Officer | $255,208 | $899,449 |
No earnings-call appearances or filed executive changes recorded yet.